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PNPLA3 GG genotype has been identiﬁed as important progression fac-
tor in patients with ALD and NAFLD. Since PNPLA3 function remains
poorly understood, we here studied genotype distribution and various
noninvasive, serum andmolecular markers of liver damage and steatosis
in 521 heavy drinkers (mean alcohol consumption 191.2 g per day) prior
and after alcohol withdrawal. Liver histologywas obtained in 80 patients
and allowed additional immunostaining for lipid droplet (LD)-associated
proteins (N = 47) and expression of mRNA transcripts (N = 24).
PNPLA3 GG carriers (8.2%) drunk signiﬁcantly less high percentage
beverages (23% vs 55%, p < 0.001) and showed no increased weight,
BMI or diabetes. Liver stiffness (LS) was signiﬁcantly elevated in G car-
riers (median 18 vs. 11 kPa) and correlated with histological signs of ﬁ-
brosis (r = 0.8) and liver damage (ballooning, r = 0.7), but not with
steatosis. In CG carrier, LS decreased signiﬁcantly from 17.6 to 12.7
but less in GG carriers. Moreover, hepatic fat content as quantiﬁed by
CAP did not signiﬁcantly differ between the groups and decreased equal-
ly by 30 dB/m. On the molecular level, key molecules, important for lip-
olysis and ﬂow of free fatty acids to the liver, were drastically reduced in
G allele carriers. These included the liver-synthesized serum ApoA1, the
LD-associated protein perilipin5 and the recently identiﬁed hepato-
protective transcriptional cofactor transducin beta-like-related 1
(TBLR1). Conclusion: In heavy drinkers, PNPLA3 GG primarily corre-
lates with hepatocyte damage resulting in a reversible, inﬂammation-
associated increase of LS and the suppression of key molecules that are
important for lipolysis and hepatocellular fat mobilization.
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